Highlights:

At the end of the trial, almost half (44.8%) of the patients following the step-wise regimen only required 1 or 2 mealtime injections a day.

The most common adverse events of greater than or equal to 5% are nasopharyngitis, influenza, diarrhea, headache, peripheral edema, and wrong drug administered.